Infiltration of glioma cells in brain parenchyma stimulated by radiation in the F98/Fischer rat model

International Journal of Radiation Biology

Volumn 88, Issue 8, 2012, Pages 565-574

  Desmarais, Guillaume ^a   Fortin, David ^a,b   Bujold, Rachel ^a,c   Wagner, Richard ^a   Mathieu, David ^a,b   Paquette, Benoit ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b Service of Neurosurgery/Neuro oncology   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Glioblastoma multiforme; Infiltration; Matrix metalloproteinase; Prostaglandin; Radiotherapy

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1BETA; NESTIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN RADIATION; BRAIN TISSUE; CELL INFILTRATION; CONTROLLED STUDY; GLIOMA CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BRAIN; CELL LINE; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; INTERMEDIATE FILAMENT PROTEINS; MALE; MICE; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; RATS; RATS, INBRED F344;

ANIMALIA; RATTUS;

EID: 84864595740     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2012.692495     Document Type: Article

References (52)

1. Ampil F, Burton GV, Gonzalez-Toledo E, Nanda A. 2007. Do we need whole brain irradiation in multifocal or multicentric high-grade cerebral gliomas? Review of cases and the literature. Journal of Neuro-Oncology 85:353-355.
2. Anscher MS. 2010. Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. The Oncologist 15:350-359.
3. Barth RF, Kaur B. 2009. Rat brain tumor models in experimental neurooncology: The C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. Journal of Neuro-Oncology 94:299-312.
4. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. 2004. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. The International Journal of iochemistry & Cell Biology 36:1046-1069.
5. Berger MS, Hadjipanayis CG. 2007. Surgery of intrinsic cerebral tumors. Neurosurgery 61:279-304.
6. Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G, Vecht C. 2008. lioblastoma in adults. Critical Reviews in Oncology / Hematology 67:139-152.
7. Brosseau JP, Lucier JF, Lapointe E, Durand M, Gendron D, Gervais-Bird J, Tremblay K, Perreault JP, Elela SA. 2010. High-throughput quantifi cation of splicing isoforms. RNA (New York, N.Y.) 16:442-449.
8. Bulnes S, Garcia-Blanco A, Bengoetxea H, Ortuzar N, Argandona EG, Lafuente JV. 2011. Glial stem cells and their relationship with tumour angiogenesis process. Revista de Neurologia 52:743-750.
9. Burger PC, Dubois PJ, Schold SC,Jr, Smith KR,Jr, Odom GL, Crafts DC, Giangaspero F. 1983. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. Journal of Neurosurgery 58:159-169.
10. Burger PC, Heinz ER, Shibata T, Kleihues P. 1988. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. Journal of Neurosurgery 68:698-704.
11. Chakravarti A, Palanichamy K. 2008. Overcoming therapeutic resistance in malignant gliomas: Current practices and future directions. Cancer Treatment and Research 139:173-189.
12. Charest G, Mathieu D, Lepage M, Fortin D, Paquette B, Sanche L. 2009. Polymer gel in rat skull to assess the accuracy of a new rat stereotactic device for use with the Gamma Knife. Acta Neurochirurgica 151:677-83.
13. Charest G, Paquette B, Fortin D, Mathieu D, Sanche L. 2010. Concomitant treatment of F98 glioma cells with new liposomal platinum compounds and ionizing radiation. Journal of Neuro-Oncology 97:187-193.
14. Chintala SK, Tonn JC, Rao JS. 1999. Matrix metalloproteinases and their biological function in human gliomas. International Journal of Developmental Neuroscience 17:495-502.
15. Christensen K, Aaberg-Jessen C, Andersen C, Goplen D, Bjerkvig R, Kristensen BW. 2010. Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium. Neurosurgery 66:933-947.
16. Conde B, Tejedor M, Sinues E, Alcala A. 1991. Modulation of cell growth and diff erentiation induced by prostaglandin D2 in the glioma cell line C6. Anticancer Research 11:289-295.
17. Cooper C, Jones HG, Weller RO, Walker V. 1984. Production of prostaglandins and thromboxane by isolated cells from intracranial tumours. Journal of Neurology, Neurosurgery and Psychiatry 47: 579-584.
18. Dell'Albani P. 2008. Stem cell markers in gliomas. Neurochemical Research 33:2407-2415.
19. Denkert C, Furstenberg A, Daniel PT, Koch I, Kobel M, Weichert W, Siegert A, Hauptmann S. 2003. Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference. Oncogene 22:8653-8661.
20. Elliott RE, Parker EC, Rush SC, Kalhorn SP, Moshel YA, Narayana A et al. 2011. Effi cacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg 76: 128-140.
21. Ellingson B, Cloughesy T, Lai A, Nghiemphu P, Pope W. 2011. Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diff usion MR images in recurrent glioblastoma treated with bevacizumab. Journal of Neuro-Oncology 105:91-101.
22. Fortin D, Desjardins A, Benko A, Niyonsega T, Boudrias M. 2005. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: The Sherbrooke experience. Cancer 103:2606-2615.
23. Gaspar LE, Fisher BJ, Macdonald DR, LeBer DV, Halperin EC, Schold SC Jr, Cairncross JG. 1992. Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment. International Journal of Radiation Oncology, Biology, Physics 24:55-57.
24. Giese A, Bjerkvig R, Berens ME, Westphal M. 2003. Cost of migration: Invasion of malignant gliomas and implications for treatment. Journal of Clinical Oncology 21:1624-1636.
25. Gilyarov AV. 2008. Nestin in central nervous system cells. Neuroscience and Behavioral Physiology 38:165-169.
26. Grossmann EM, Longo WE, Mazuski JE, Panesar N, Kaminski DL. 2000. Role of cytosolic phospholipase A2 in cytokine-stimulated prostaglandin release by human gallbladder cells. Journal of Gastrointestinal Surgery 4:193-200.
27. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. 2007. qBase relative quantifi cation framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biology 8:R19.
28. Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T. 2006. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Research 66:2067-2073.
29. Johannesen TB, Lien HH, Hole KH, Lote K. 2003. Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiotherapy and Oncology 69:169-176.
30. Kitai R, Horita R, Sato K, Yoshida K, Arishima H, Higashino Y, Hashimoto N, Takeuchi H, Kubota T, Kikuta K. 2010. Nestin expression in astrocytic tumors delineates tumor infi ltration. Brain Tumor Pathology 27:17-21.
31. Kyrkanides S, Moore AH, Olschowka JA, Daeschner JC, Williams JP, Hansen JT, Kerry O'Banion M. 2002. Cyclooxygenase-2 modulates brain infl ammation-related gene expression in central nervous system radiation injury. Brain Research. Molecular Brain Research 104:159-169.
32. Lee WH, Sonntag WE, Mitschelen M, Yan H, Lee YW. 2010. Irradiation induces regionally specifi c alterations in pro-infl ammatory environments in rat brain. International Journal of Radiation Biology 86:132-144.
33. Lemay R, Archambault M, Tremblay L, Bujold R, Lepage M, Paquette B. 2011. Irradiation of normal mouse tissue increases the invasiveness of mammary cancer cells. International Journal of Radiation Biology 87:472-482.
34. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. 2007. The 2007 WHO classifi cation of tumours of the central nervous system. Acta Neuropathologica 114:97-109.
35. Liu W, Ding I, Chen K, Olschowka J, Xu J, Hu D et al. 2006. Interleukin 1beta (IL-1) signaling is a critical component of radiation-induced skin fi brosis. Radiation Research 165:181-191.
36. Maccarrone M, Nieuwenhuizen WE, Dullens HF, Catani MV, Melino G, Veldink GA, Vliegenthart JF, Finazzo Agro A. 1996. Membrane modifi cations in human erythroleukemia K562 cells during induction of programmed cell death by transforming growth factor beta 1 or cisplatin. European Journal of Biochemistry 241:297-302.
37. Mangiola A, Anile C, Pompucci A, Capone G, Rigante L, De Bonis P. 2010. Glioblastoma therapy: Going beyond Hercules Columns. Expert Review of Neurotherapeutics 10:507-514.
38. Mathieu D, Lecomte R, Tsanaclis AM, Larouche A, Fortin D. 2007. Standardization and detailed characterization of the syngeneic Fischer/ F98 glioma model. The Canadian Journal of eurological Sciences 34:296-306.
39. Niewald M, Berdel C, Fleckenstein J, Licht N, Ketter R, Rube C. 2011. Toxicity after radiochemotherapy for glioblastoma using temozolomide-a retrospective evaluation. Radiation Oncology 6:141.
40. Noonan DM, De Lerma Barbaro A, Vannini N, Mortara L, Albini A. 2008. Infl ammation, infl ammatory cells and angiogenesis: Decisions and indecisions. Cancer Metastasis Reviews 27:31-40.
41. Park CM, Park MJ, Kwak HJ, Lee HC, Kim MS, Lee SH, Park IC, Rhee CH, Hong SI. 2006. Ionizing radiation enhances matrix metalloproteinase- 2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Research 66: 8511-8519.
42. Park KJ, Kano H, Iyer A, Liu X, Niranjan A, Flickinger JC et al. 2012. Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: A case-control study. Journal of Neuro-Oncology 107:323-333.
43. Picard N, Ali H, Van Lier JE, Klarskov K, Paquette B. 2009. Bromines on N-allyl position of cationic porphyrins aff ect both radio- and photosensitizing properties. Photochemical & photobiological sciences 8:224-232.
44. Roth P, Wick W, Weller M. 2010. Steroids in neurooncology: Actions, indications, side-eff ects. Current Opinion in Neurology 23:597-602.
45. Rutka JT, Apodaca G, Stern R, Rosenblum M. 1988. The extracellular matrix of the central and peripheral nervous systems: Structure and function. Journal of Neurosurgery 9:155-170.
46. Tamagno I, Schiff er D. 2006. Nestin expression in reactive astrocytes of human pathology. Journal of Neuro-Oncology 80:227-233.
47. Tjandrawinata RR, Dahiya R, Hughes-Fulford M. 1997. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. British Journal of Cancer 75:1111-1118.
48. Vecht CJ. 1998. Clinical management of brain metastasis. Journal of Neurology 245:127-131.
49. Wick W, Platten M, Weller M. 2001. Glioma cell invasion: Regulation of metalloproteinase activity by TGF-beta. Journal of Neuro-Oncology 53:177-185.
50. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. 2001. Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma. Cancer Research 61:2744-2750.
51. Yamanaka N, Morisaki T, Nakashima H, Tasaki A, Kubo M, Kuga H et al. 2004. Interleukin 1beta enhances invasive ability of gastric carcinoma through nuclear factor-kappaB activation. Clinical Cancer Research 10:1853-1859.
52. Zhai GG, Malhotra R, Delaney M, Latham D, Nestler U, Zhang M, Mukherjee N, Song Q, Robe P, Chakravarti A. 2006. Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. Journal of Neuro-Oncology 76:227-237.